Loading...
Loading...
RetinalGenix Technologies Inc.
RetinalGenix Technologies Inc.. Spoken Alpha tracks RTGN's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks RTGN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 100% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RTGN.
curl https://api.spokenalpha.com/v1/companies/RTGN| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.59 | $3.98 | +15.4% | -5.4% | -6.7% |
| Q4 FY2026 | $4.79 | $4.23 | +13.3% | -0.8% | -0.4% |
| Q3 FY2026 | $4.66 | $4.16 | +11.9% | -5.1% | -3.5% |
| Q2 FY2026 | $4.47 | $4.11 | +8.7% | -3.5% | -5.8% |
| Q1 FY2025 | $4.45 | $4.17 | +6.8% | -3.3% | -2.2% |
| Q4 FY2025 | $4.63 | $4.18 | +10.7% | -4.7% | -6.8% |
| Q3 FY2025 | $4.46 | $4.21 | +6.0% | -5.9% | -3.2% |
| Q2 FY2025 | $5.13 | $4.30 | +19.4% | -5.1% | -4.8% |
| Q1 FY2024 | $4.78 | $4.36 | +9.7% | -3.3% | -1.4% |
| Q4 FY2024 | $4.87 | $4.25 | +14.5% | -0.2% | +0.7% |